Insights

The Prescient (ASX: PTX) share price is surging 12%. Here’s why

It’s been a wild ride for the Prescient Therapeutics share price lately.
The post The Prescient (ASX: PTX) share price is surging 12%. Here’s why appeared first on The Motley Fool Australia. –

The Prescient Therapeutics Ltd (ASX: PTX) share price is soaring today, despite the company not releasing any news.

The last time we heard price-sensitive news from the biotechnology company was on 5 July.

Right now, the Prescient Therapeutics share price is 23 cents – 12.2% higher than it was at close of market yesterday. 

Prescient Therapeutics focuses on therapies for cancer treatment. Let’s take a closer look at what the company has been up to lately.

The month that’s been for Prescient

Over the last 30 days, 2 major announcements saw the Prescient Therapeutics share price moving dramatically.

The first was on 24 June, when the company released news of its next-generation immunotherapy platform.

Prescient Therapeutics told the market it had incorporated SpyTag into binders for its 3 next-generation CAR-T programs.

The company also received lentiviral vectors that will help produce CAR-T cells expressing SpyCatcher.

Despite the seemingly positive news, the Prescient Therapeutics share price fell 13% that day and another 5% the day after.

Then, on 5 July, the company announced immunogenicity testing had been completed on the company’s OmniCAR therapy.

The components of OmniCAR, which include SpyTag and SpyCatcher, received positive results from in silico immunogenicity testing. The testing substantially de-risked OmniCAR.

In silico tests are those done using computer modelling. In this case, they simulated the body’s response to OmniCAR.

Following the news, the Prescient Therapeutics share price gained 13%.

However, between market close on July 5 and market close yesterday, the company’s share price fell 19%.

Fortunately, today has helped to turn the plunge around.

 Prescient Therapeutics share price snapshot

Prescient Therapeutics is going well on the ASX lately.

Its share price is currently 243% higher than it was at the beginning of 2021.

The company has a market capitalisation of around $147 million, with approximately 641 million shares outstanding.  

The post The Prescient (ASX: PTX) share price is surging 12%. Here’s why appeared first on The Motley Fool Australia.

Should you invest $1,000 in Prescient Therapeutics right now?

Before you consider Prescient Therapeutics, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Prescient Therapeutics wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

Why is the Prescient (ASX:PTX) share price down 16% this week?
The Prescient (ASX:PTX) share price rocketed 10% higher today. Here’s why
Prescient (ASX:PTX) share price sinks despite positive update

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!